Analysis of risk evaluation and mitigation strategies for teratogenic drugs: Variation in primary and secondary prevention measures.
review · Level V
Where this comes from
- Record sourced from PubMed, PMID 36877723.
- Also identified by DOI 10.1371/journal.pmed.1004190 and PMC identifier 9987786.
- Licence recorded as CC BY.
- The licence permits redistribution, so the abstract is shown in full and the full text is available from the publisher.
Abstract
In an analysis of risk evaluation and mitigation strategies for teratogenic drugs, Ameet Sarpatwari, Beatrice Brown and Aaron Kesselheim explore the variation in primary and secondary prevention measures.
Medical subject headings
- Teratogens
- Risk Evaluation and Mitigation